Detection of blaKPC and blaNDM carbapenemases genes in Klebsiella pneumoniae isolates from San Juan de Dios General Hospital in Guatemala City, Guatemala

Authors

  • Tamara Velásquez Porta Facultad de Ciencias Químicas y Farmacia, Universidad de San Carlos de Guatemala.
  • Dalia Lau Bonilla Asociación de Salud Integral.

Keywords:

carbapenemases, blaNDM gene, blaKPC gene, Klebsiella pneumoniae.

Abstract

Resistance to antibiotics is one of the most important public health problems worldwide. Enterobacteriaceae, producers of carbapenemases, pose the greatest threat. Carbapenemases are powerful enzymes that inactivate carbapenem antibiotics and generally all beta-lactam antibiotics. The consequences that result from treating infections caused by these bacteria are important because carbapenems are the latest options available for multidrug-resistant bacteria. This research aimed to determine by the means of endpoint polymerase chain reaction (PCR), the presence of blaKPC (Klebsiella pneumoniae carbapenemase) and blaNDM (New Delhi metallolactamase) carbapenemases genes in Klebsiella pneumoniae isolates from San Juan de Dios General Hospital located in Guatemala City; to characterize the sample type and determine the area of the hospital where such bacteria were isolated. 54 Klebsiella pneumoniae isolates resistant to carbapenems (imipenem and / or meropenem), were analyzed. From these, 49 (91 %) were detected as blaNDM gene carriers. These bacteria were more frequently isolated in blood (37%) and urine (14%) samples. In this research, 53% of the isolates were obtained from patients hospitalized in intensive care units. This study demonstrates that Klebsiella pneumoniae harboring blaNDM gene has spread within San Juan de Dios General Hospital, since the first reported case 5 years ago, risking the life of patients, especially of those hospitalized in intensive care units.

 

References

Centro para el Control y Prevención de las Enfermedades (CDC). 2015. Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE). Estados Unidos: Autor.

Coronado, E. (2015) Salvar vidas en un hospital en donde no sirve ni el ascensor. Revista Contrapoder, 110

Garrido Ortega, M. A. (2014). Determinación de carbapenemasas en aislamientos de Escherichia coli y Klebsiella sp. aisladas en el Hospital General San Juan de Dios. (Tesis de Licenciatura). Universidad de San Carlos de Guatemala.Guatemala.

Hospital General San Juan de Dios. Departamento de Informática. (2015). Reporte 2015 de producción Hospital General San Juan de Dios. Guatemala: Autor.

Johnson, A. P., & Woodford, N. (2013). Global spread of antibiotic resistance: The example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. Journal of Medical Microbiology, 62(4), 499–513. http://doi.org/10.1099/jmm.0.052555-0

Martínez-Martínez, L., & González-López, J. J. (2014). Carbapenemases in Enterobacteriaceae: types and molecular epidemiology. Enfermedades Infecciosas y Microbiología Clínica, 32(4), 4–9. http://doi.org/10.1016/S0213-005X(14)70168-5

Organización Panamericana de la Salud. (2012). Alerta epidemiológica: transmisión de bacterias multirresistentes tipo NDM en servicios de atención de salud. Recuperado de http://antimicrobianos.com.ar/ATB/wp-content/uploads/2014/03/Transmisi%C3%B3n-de-bacterias-multirresistentes-tipo.pdf

Paño Pardo, J. R., Villar, S. S., Ramos Ramos, J. C., & Pintado, V. (2014). Infections caused by carbapenemase-producing Enterobacteriaceae: Risk factors, clinical features and prognosis. Enfermedades Infecciosas y Microbiología Clínica, 32 Suppl 4(4), 41–8. http://doi.org/10.1016/S0213-005X(14)70173-9

Pasteran, F., Albornoz, E., Faccone, D., Gomez, S., Valenzuela, C., Morales, M., … Corso, A. (2012). Emergence of NDM-1-producing Klebsiella pneumoniae in Guatemala. Journal of Antimicrobial Chemotherapy, 67, (7), 1795–1797. http://doi.org/10.1093/jac/dks101

Pitout, J. D. D., Nordmann, P., & Poirel, L. (2015). Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance: TABLE 1. Antimicrobial Agents and Chemotherapy, 59(10), 5873–5884. http://doi.org/10.1128/AAC.01019-15

Promega Corporation. (2009). Wizard ® Genomic DNA Purification Kit Wizard ® Genomic DNA. Solutions.Estados Unidos: Autor.

Rosales, M. (2015). Crisis hospitalaria en Guatemala es la peor de su historia. Recuperado de http://www.telesurtv.net/news

Servicio Antimicrobianos, I. N. de E. I.-A. "Dr. C. G. M. (2008 y 2012).

Protocolo de PCR para la detección del gen kpc en aislamientos de bacilos gram-negativos. Instituto de Salud (ANLIS) “Dr. Carlos G. Malbrán.†Recuperado de http://antimicrobianos.com.ar/ATB/wp-content/uploads/2013/02/Detección-KPC.pdf

Downloads

Published

2017-04-24

Issue

Section

Artículos